Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05495841 · ClinicalTrials.gov registry record

OPTiMASK: Comparison of Pre-oxygenation With Standard Face Mask Combined With High Flow Nasal Oxygen With Pre-oxygenation With Standard Face Mask Alone

A clinical trial of Surgery, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
80
Enrollment target
1
Study location

NCT05495841 is a study of Surgery that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 80 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05495841, a study of Surgery, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

This is an observational, prospective study of patients undergoing a surgical procedure. Three parallel studies are taking place with collaborators in other countries. This study aims to bring novel insights regarding the benefits of pre-oxygenation combining standard oxygen facemask with high-flow nasal oxygen (HFNO), as opposed to standard oxygen facemask alone by assessing end-tidal oxygen (ETO2) levels after intubation.

Conditions Studied

Interventions

  • DEVICE Pre-oxygenation

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-08-18
Est. Completion 2023-06-30

What the Registry Record Tells You About NCT05495841

The ClinicalTrials.gov registry entry for NCT05495841 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which Pre-oxygenation is the first listed.

NCT05495841 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05495841 about?

NCT05495841 is a clinical study titled "OPTiMASK: Comparison of Pre-oxygenation With Standard Face Mask Combined With High Flow Nasal Oxygen With Pre-oxygenation With Standard Face Mask Alone". This is an observational, prospective study of patients undergoing a surgical procedure. Three parallel studies are taking place with collaborators in other countries. This study aims to bring novel insights regarding the benefits of pre-oxygenation combining standard oxygen facemask with high-flow ...

What is the current status of trial NCT05495841?

This trial is currently completed. The enrollment target is 80 participants. The study started on 2022-08-18. Estimated completion is 2023-06-30.

What conditions does trial NCT05495841 study?

This clinical trial studies the following conditions: Surgery.

What interventions are being tested in trial NCT05495841?

The interventions under investigation include: Pre-oxygenation (DEVICE).

Who is sponsoring clinical trial NCT05495841?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05495841 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.